melanosome aggregation by melatonin ( Figure 1A) , whereas the inactive analog U0124 had no effect. In Urbana, Illinois 61801 addition, treatment with U0126 did not prevent melanocyte-stimulating hormone (MSH)-dependent melanosome dispersion ( Figure 1B ). 
cytoskeleton.
ERK Signaling Does Not Affect Lysosome Movements
Transient Activation of MEK, ERK, and Melanosome Transport during Aggregation In order to determine whether ERK signaling specifically regulates melanosome transport, we chose to study the In light of the dramatic melanosome-transport changes obtained by manipulating the ERK pathway and of the effect of U0126 on the transport of lysosomes, organelles related to melanosomes but transported by differ-U0126-dependent block of aggregation, it is important to understand the kinetics of ERK signaling and melanoent motor proteins and subject to different regulatory mechanisms [5, 11] . Analysis of lysosome transport (Tasome movements during melatonin treatment. We observed dramatic activation of MEK and ERK in melanoble 2; Figure S5 ) demonstrates that inhibition of ERK signaling by U0126 has no effect on lysosome transport phore extracts within the first 5 min of melatonin treatment; the activation subsides as treatment time in either melatonin-or MSH-treated cells, indicating that ERK regulatory effects are specific for melanosome increases ( Figure 2A , top panels). These observations 
